These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 7481582)

  • 1. Serum values of pepsinogens and antibodies to Helicobacter pylori in relation to a history of peptic ulcer disease and NSAID use.
    Janssen M; Dijkmans BA; Vandenbroucke JP; Biemond I; van Duyn W; Zwinderman AH; Lamers CB
    Scand J Rheumatol; 1995; 24(4):204-8. PubMed ID: 7481582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clinical usefulness of serum pepsinogens, specific IgG anti-HP antibodies and gastrin for monitoring Helicobacter pylori treatment in older people.
    Pilotto A; Franceschi M; Leandro G; DiMario F; Soffiati G; Scagnelli M; Bozzola L; Fabrello R; Valerio G
    J Am Geriatr Soc; 1996 Jun; 44(6):665-70. PubMed ID: 8642157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Etiology and treatment of childhood peptic ulcer disease in Taiwan: a single center 9-year experience.
    Huang SC; Sheu BS; Lee SC; Yang HB; Yang YJ
    J Formos Med Assoc; 2010 Jan; 109(1):75-81. PubMed ID: 20123589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum anti-Helicobacter pylori IgG antibodies and pepsinogens A and C as serological markers of chronic atrophic gastritis.
    Sitas F; Smallwood R; Jewell D; Millard PR; Newell DG; Meuwissen SG; Moses S; Zwiers A; Forman D
    Cancer Epidemiol Biomarkers Prev; 1993; 2(2):119-23. PubMed ID: 8467246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cure of Helicobacter pylori infection in the elderly: effects of eradication on gastritis and serological markers.
    Pilotto A; Di Mario F; Franceschi M; Leandro G; Soffiati G; Scagnelli M; Bozzola L; Valerio G
    Aliment Pharmacol Ther; 1996 Dec; 10(6):1021-7. PubMed ID: 8971305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum CagA antibodies in asymptomatic subjects and patients with peptic ulcer: lack of correlation of IgG antibody in patients with peptic ulcer or asymptomatic Helicobacter pylori gastritis.
    Graham DY; Genta RM; Graham DP; Crabtree JE
    J Clin Pathol; 1996 Oct; 49(10):829-32. PubMed ID: 8943750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eradication of Helicobacter pylori infection reduces the incidence of peptic ulcer disease in patients using nonsteroidal anti-inflammatory drugs: a meta-analysis.
    Tang CL; Ye F; Liu W; Pan XL; Qian J; Zhang GX
    Helicobacter; 2012 Aug; 17(4):286-96. PubMed ID: 22759329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Helicobacter pylori genotypes influence serum pepsinogen C levels.
    Plebani M; Basso D; Navaglia F; DiMario F
    Helicobacter; 1997 Dec; 2(4):172-5. PubMed ID: 9421118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seroepidemiology of gastritis in Japanese and Dutch working populations: evidence for the development of atrophic gastritis that is not related to Helicobacter pylori.
    Schlemper RJ; van der Werf SD; Vandenbroucke JP; Biemond I; Lamers CB
    Gut; 1995 Aug; 37(2):199-204. PubMed ID: 7557568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seroepidemiology of gastritis in Japanese and Dutch male employees with and without ulcer disease.
    Schlemper RJ; van der Werf SD; Biemond I; Lamers CB
    Eur J Gastroenterol Hepatol; 1996 Jan; 8(1):33-9. PubMed ID: 8900906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum pepsinogen I and II concentrations and IgG antibody to Helicobacter pylori in dyspeptic patients.
    Biasco G; Paganelli GM; Vaira D; Holton J; Di Febo G; Brillanti S; Miglioli M; Barbara L; Samloff IM
    J Clin Pathol; 1993 Sep; 46(9):826-8. PubMed ID: 8227432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Helicobacter pylori CagA antigen antibodies].
    Havlasová J; Bures J; Rejchrt S; Voxová B; Krejsek J
    Cas Lek Cesk; 1998 Jun; 137(13):404-9. PubMed ID: 9748734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors of peptic ulcer disease: different impact of Helicobacter pylori in Dutch and Japanese populations?
    Schlemper RJ; van der Werf SD; Vandenbroucke JP; Biemond I; Lamers CB
    J Gastroenterol Hepatol; 1996 Sep; 11(9):825-31. PubMed ID: 8889960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Changes in serum anti-Helicobacter pylori IgG antibody, pepsinogen I, pepsinogen II after eradication therapy of Helicobacter pylori].
    Matuskawa Y
    Nihon Shokakibyo Gakkai Zasshi; 1998 May; 95(5):460. PubMed ID: 9621705
    [No Abstract]   [Full Text] [Related]  

  • 15. Childhood peptic ulcer in the Ural area of Russia: clinical status and Helicobacter pylori-associated immune response.
    Nijevitch AA; Sataev VU; Vakhitov VA; Loguinovskaya VV; Kotsenko TM
    J Pediatr Gastroenterol Nutr; 2001 Nov; 33(5):558-64. PubMed ID: 11740229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of non-steroidal anti-inflammatory drug and aspirin use on the prevalence of dyspepsia and uncomplicated peptic ulcer disease.
    Voutilainen M; Mäntynen T; Färkkilä M; Juhola M; Sipponen P
    Scand J Gastroenterol; 2001 Aug; 36(8):817-21. PubMed ID: 11495076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum pepsinogens, gastrin-17 and Helicobacter pylori antibody in the residents of two cities in china with distinct mortality rates of gastric cancer.
    Zheng KC; Aoki K; Li XQ; Lin SG; Wu BS; Zhong WL; Chen TH; Lin S; You JW; Su C
    Tohoku J Exp Med; 2012 Dec; 228(4):289-94. PubMed ID: 23117263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating anti-Helicobacter pylori immunoglobulin A antibodies and low serum pepsinogen I level are associated with increased risk of gastric cancer.
    Aromaa A; Kosunen TU; Knekt P; Maatela J; Teppo L; Heinonen OP; Härkönen M; Hakama MK
    Am J Epidemiol; 1996 Jul; 144(2):142-9. PubMed ID: 8678045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Helicobacter pylori IgA antibodies with the risk of peptic ulcer disease and gastric cancer.
    Kosunen TU; Seppala K; Sarna S; Aromaa A; Knekt P; Virtamo J; Salomaa-Rasanen A; Rautelin H
    World J Gastroenterol; 2005 Nov; 11(43):6871-4. PubMed ID: 16425400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening of atrophic gastritis and gastric cancer by serum pepsinogen, gastrin-17 and Helicobacter pylori immunoglobulin G antibodies.
    Cao Q; Ran ZH; Xiao SD
    J Dig Dis; 2007 Feb; 8(1):15-22. PubMed ID: 17261130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.